WallStreetZenWallStreetZen

NASDAQ: PCSA
Processa Pharmaceuticals Inc Stock Ownership - Who owns Processa Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Processa Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David 1. YoungPres. Research Development2026-05-291,786$2.57
$4.59kBuy
Russell SkibstedChief Financial Officer2026-05-292,292$2.57
$5.89kBuy
Patrick LinChief Business - Strategy Off2026-05-291,582$2.57
$4.07kBuy
Wendy GuyChief Administrative Officer2026-05-291,829$2.57
$4.70kBuy
George K. NgChief Executive Officer2026-05-292,129$2.57
$5.47kBuy
David 1. YoungPres. Research Development2026-05-151,545$2.97
$4.59kBuy
George K. NgChief Executive Officer2026-05-151,843$2.97
$5.47kBuy
Russell SkibstedChief Financial Officer2026-05-151,984$2.97
$5.89kBuy
Patrick LinChief Business - Strategy Off2026-05-151,369$2.97
$4.07kBuy
Wendy GuyChief Administrative Officer2026-05-151,583$2.97
$4.70kBuy

1 of 4

PCSA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PCSA insiders and whales buy or sell their stock.

PCSA Shareholders

What type of owners hold Processa Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James E. Besser53.03%1,458,300$3.16MInsider
Justin W. Yorke40.87%1,124,049$2.44MInsider
Virgil Thompson8.75%240,755$522.44kInsider
Khalid Islam7.03%193,395$419.67kInsider
Robert Michael Floyd6.26%172,061$373.37kInsider
George K. Ng4.42%121,458$263.56kInsider
Connective Capital Management LLC2.57%70,736$153.50kInstitution
Stonepine Capital Management LLC2.00%55,000$119.35kInstitution
Geode Capital Management LLC0.91%24,908$54.05kInstitution
David 1. Young0.71%19,547$42.42kInsider

1 of 3

PCSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PCSA4.99%95.01%Net BuyingNet Buying
XTLB0.01%12.85%
EVGN5.10%0.84%
ADIL1.10%98.90%
BCAB54.60%45.40%Net SellingNet Selling
View Top Biotech Stocks

Processa Pharmaceuticals Stock Ownership FAQ

Who owns Processa Pharmaceuticals?

Processa Pharmaceuticals (NASDAQ: PCSA) is owned by 6.46% institutional shareholders, 122.94% Processa Pharmaceuticals insiders, and 0.00% retail investors. James E. Besser is the largest individual Processa Pharmaceuticals shareholder, owning 1.46M shares representing 53.03% of the company. James E. Besser's Processa Pharmaceuticals shares are currently valued at $3.22M.

If you're new to stock investing, here's how to buy Processa Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.